AJMC.com: As Metformin Combinations Proliferate, Questions Arise About Value

September 10, 2016

Earlier this year, when the FDA granted initial approval to Jentadueto XR and a first-line indication to Invokamet, it gave fresh momentum to an entire category of medications: single pills that combine metformin with some other treatment for type 2 diabetes (T2D).  – See more at: http://www.ajmc.com/journals/evidence-based-diabetes-management/2016/september-2016/as-metformin-combinations-proliferate-questions-arise-about-value#sthash.jAAOQ94L.dpuf Read the full story at AJMC.com






KSAT 12: Local doctors co-author study on MRSA pneumonia

September 10, 2016

Researchers at The University of Texas Health Science Center at San Antonio said doctors in the Alamo City may be overprescribing antibiotics for patients diagnosed with pneumonia after they were exposed to an MRSA infection. Watch the full story at KSAT 12